We speculate that interventions targeting the activation pathway of CD4+ T cell subpopulations, such as down-regulation of HIF-1α or inhibition of hypoxic microenvironment, may reduce the expansion and function of CD4+ T cells, thereby inhibiting the initiation or persistence of SLE. This evidence concerns the gene HIF1A and systemic lupus erythematosus.